GeneDx Holdings (WGS) Cash from investing

annual CFI:

-$30.13M+$13.59M(+31.09%)
December 31, 2024

Summary

  • As of today (May 29, 2025), WGS annual cash flow from investing activities is -$30.13 million, with the most recent change of +$13.59 million (+31.09%) on December 31, 2024.
  • During the last 3 years, WGS annual CFI has fallen by -$9.35 million (-44.96%).
  • WGS annual CFI is now -94.95% below its all-time high of -$15.46 million, reached on December 1, 2019.

Performance

WGS Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWGScash flow metrics

quarterly CFI:

-$9.41M-$8.89M(-1712.72%)
March 31, 2025

Summary

  • As of today (May 29, 2025), WGS quarterly cash flow from investing activities is -$9.41 million, with the most recent change of -$8.89 million (-1712.72%) on March 31, 2025.
  • Over the past year, WGS quarterly CFI has dropped by -$10.25 million (-1216.01%).
  • WGS quarterly CFI is now -1216.01% below its all-time high of $843.00 thousand, reached on March 31, 2024.

Performance

WGS quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWGScash flow metrics

TTM CFI:

-$40.38M-$10.25M(-34.02%)
March 31, 2025

Summary

  • As of today (May 29, 2025), WGS TTM cash flow from investing activities is -$40.38 million, with the most recent change of -$10.25 million (-34.02%) on March 31, 2025.
  • Over the past year, WGS TTM CFI has increased by +$2.04 million (+4.80%).
  • WGS TTM CFI is now -708.63% below its all-time high of -$4.99 million, reached on March 1, 2021.

Performance

WGS TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWGScash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

WGS Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+31.1%-1216.0%+4.8%
3 y3 years-45.0%-140.4%-104.9%
5 y5 years-95.0%--

WGS Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-45.0%+78.7%-1216.0%+92.8%-114.2%+72.4%
5 y5-year-95.0%+78.7%-1216.0%+92.8%-708.6%+72.4%
alltimeall time-95.0%+78.7%-1216.0%+92.8%-708.6%+72.4%

WGS Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$9.41M(+1712.7%)
-$40.38M(+34.0%)
Dec 2024
-$30.13M(-31.1%)
-$519.00K(-93.3%)
-$30.13M(-12.6%)
Sep 2024
-
-$7.75M(-65.8%)
-$34.48M(-36.0%)
Jun 2024
-
-$22.70M(-2792.9%)
-$53.85M(+26.9%)
Mar 2024
-
$843.00K(-117.3%)
-$42.42M(-3.0%)
Dec 2023
-$43.73M(-69.1%)
-$4.86M(-82.1%)
-$43.73M(+4.9%)
Sep 2023
-
-$27.13M(+140.7%)
-$41.70M(+121.2%)
Jun 2023
-
-$11.27M(+2339.6%)
-$18.85M(-86.3%)
Mar 2023
-
-$462.00K(-83.7%)
-$137.88M(-2.4%)
Dec 2022
-$141.33M
-$2.84M(-33.7%)
-$141.33M(-3.3%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$4.28M(-96.7%)
-$146.18M(+0.5%)
Jun 2022
-
-$130.30M(+3229.8%)
-$145.52M(+638.5%)
Mar 2022
-
-$3.91M(-49.1%)
-$19.70M(-5.2%)
Dec 2021
-$20.79M(-35.0%)
-
-
Dec 2021
-
-$7.69M(+112.6%)
-$20.79M(+58.8%)
Sep 2021
-
-$3.62M(-19.3%)
-$13.09M(+38.2%)
Jun 2021
-
-$4.48M(-10.3%)
-$9.47M(+89.7%)
Mar 2021
-
-$4.99M
-$4.99M
Dec 2020
-$31.97M(+106.9%)
-
-
Dec 2019
-$15.46M
-
-

FAQ

  • What is GeneDx Holdings annual cash flow from investing activities?
  • What is the all time high annual CFI for GeneDx Holdings?
  • What is GeneDx Holdings annual CFI year-on-year change?
  • What is GeneDx Holdings quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for GeneDx Holdings?
  • What is GeneDx Holdings quarterly CFI year-on-year change?
  • What is GeneDx Holdings TTM cash flow from investing activities?
  • What is the all time high TTM CFI for GeneDx Holdings?
  • What is GeneDx Holdings TTM CFI year-on-year change?

What is GeneDx Holdings annual cash flow from investing activities?

The current annual CFI of WGS is -$30.13M

What is the all time high annual CFI for GeneDx Holdings?

GeneDx Holdings all-time high annual cash flow from investing activities is -$15.46M

What is GeneDx Holdings annual CFI year-on-year change?

Over the past year, WGS annual cash flow from investing activities has changed by +$13.59M (+31.09%)

What is GeneDx Holdings quarterly cash flow from investing activities?

The current quarterly CFI of WGS is -$9.41M

What is the all time high quarterly CFI for GeneDx Holdings?

GeneDx Holdings all-time high quarterly cash flow from investing activities is $843.00K

What is GeneDx Holdings quarterly CFI year-on-year change?

Over the past year, WGS quarterly cash flow from investing activities has changed by -$10.25M (-1216.01%)

What is GeneDx Holdings TTM cash flow from investing activities?

The current TTM CFI of WGS is -$40.38M

What is the all time high TTM CFI for GeneDx Holdings?

GeneDx Holdings all-time high TTM cash flow from investing activities is -$4.99M

What is GeneDx Holdings TTM CFI year-on-year change?

Over the past year, WGS TTM cash flow from investing activities has changed by +$2.04M (+4.80%)
On this page